Subscribe to our RSS feeds RSS | Login | Register  
 

 Approval Articles

Product news

October 11, 2007

Boehringer Ingelheim Pharmaceuticals announced that the FDA has granted full approval of Aptivus (tipranavir) capsules.
 

Product news

September 27, 2007

Sanofi-Aventis and Bristol-Myers Squibb said the FDA Administration has approved a supplemental new drug application for a 300 mg tablet of the antiplatelet drug Plavix (clopidogrel bisulfate).
 

Product news

September 25, 2007

GlaxoSmithKline announced that the European Commission has granted a marketing authorization for its cervical cancer vaccine, Cervarix, for all 27 European member states.
 

AZ/MedImmune's FluMist gets big boost with new indication

Matthew Arnold September 19, 2007

MedImmune announced that the FDA has approved the use of its FluMist in children 2-5 years old, an indication that significantly expands the market for the nasal vaccine.
 

Product news

September 18, 2007

The FDA approved Eli Lillys osteoporosis drug Evista to reduce breast cancer risk in some postmenopausal women.
 

Product news

September 11, 2007

Quinnova Pharmaceuticals announced the commercial launch of Tersi Foam, (2.25% selenium sulfide) for the treatment of seborrheic dermatitis and tinea versicolor of the skin.
 

FDA approves new vaccine for smallpox

Stephen McGuire September 04, 2007

The FDA has approved a new vaccine against smallpox which could be quickly made if the virtually extinct virus were to reappear.
 

Product news

September 04, 2007

The FDA has approved Evithrom (human thrombin), a blood-clotting protein used to help control bleeding during surgery.
 

New approval for drug gives Novartis excuse to up promotion

August 20, 2007

The newest indication for Reclast -- postmenopausal osteoporosis -- ups its market potential considerably, analysts said.
 

Key advisor: FDA should hold diabetes drugs to different standard

Marc Iskowitz August 09, 2007

In an opinion piece yesterday, the chair of the FDA advisory committee on Avandia recommended the agency change the way it evaluates experimental diabetes drugs.